Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Stud Health Technol Inform ; 94: 410-2, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-15455937

RESUMO

Based upon the idea that both facial appearance and functional outcomes of the craniofacial surgery need to be predicted in the pre-surgery planning stage, a CACSP system has been established. In this system, the input is in vivo CT/MRI scan data of patient with craniofacial deformity, anatomical restoration is simulated using the medical visualization packages ANALYZE, and the finite element analysis of the masticatory system has been integrated to predict the functional improvement such as bite force alteration. Preliminary studies in this laboratory have revealed the potential of this system.


Assuntos
Anormalidades Craniofaciais/cirurgia , Cirurgia Assistida por Computador , Adolescente , Humanos , Masculino , Procedimentos Cirúrgicos Ortognáticos
2.
Stud Health Technol Inform ; 85: 593-6, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-15458158

RESUMO

This paper presents our experience in using FE modeling of clinically relevant cases specifically in mandibular surgery. A semi-automatic procedure integrated with a group of Virtual Basic-based codes has been developed to clean the geometric models. Consequently, the time required for generate the tetrahedral volumetric mesh of mandible from patient-specific CT data has been reduced to less than 40 hours. Pre- and post-operation FE meshes are shown to be consistent and can be used for further modeling and analysis.


Assuntos
Gráficos por Computador , Simulação por Computador , Análise de Elementos Finitos , Processamento de Imagem Assistida por Computador , Imageamento Tridimensional , Mandíbula/anatomia & histologia , Avanço Mandibular , Modelos Teóricos , Interface Usuário-Computador , Humanos , Imageamento por Ressonância Magnética , Mandíbula/cirurgia , Software , Cirurgia Assistida por Computador , Tomografia Computadorizada por Raios X
3.
Vaccine ; 19(13-14): 1717-26, 2001 Feb 08.
Artigo em Inglês | MEDLINE | ID: mdl-11166896

RESUMO

Streptococcus pneumoniae is a leading cause of morbidity and mortality in both the developing and developed world. The T-independent nature of the current polysaccharide vaccine renders it ineffective in elderly adults and children <2 years of age. Although the recently licensed conjugate vaccines are capable of producing T-cell-dependent immunity, they also have their limitations, namely a lack of response in certain populations. Our laboratory has focused on a different approach, DNA vaccination. We have defined a peptide sequence (pep4) that mimics the S. pneumoniae serotype 4 capsular polysaccharide (PPS4) using a monoclonal antibody to PPS4 (mAb4) and phage display library. Pep4 was synthesized, complexed to proteosomes and used to immunize mice. We have shown by ELISA that this peptide mimic is capable of eliciting an anti-PPS4 immune response significantly higher than in negative control mice (P<0.05). A PPS4-DNA vaccine was made by cloning an oligodeoxynucleotide encoding pep4 into the HBcAg vector. Following epidermal immunization with the PPS4-DNA vaccine, mice produced an anti-PPS4 antibody response significantly higher than in mice immunized with an impertinent DNA vector (P<0.05). Our results demonstrate the feasibility of peptide mimicry in DNA vaccine development.


Assuntos
Anticorpos Antibacterianos/imunologia , Mimetismo Molecular/imunologia , Peptídeos/imunologia , Polissacarídeos Bacterianos/química , Polissacarídeos Bacterianos/imunologia , Streptococcus pneumoniae/imunologia , Vacinas de DNA/imunologia , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais/imunologia , Afinidade de Anticorpos , Especificidade de Anticorpos/imunologia , Sequência de Bases , Clonagem Molecular , Sistemas de Liberação de Medicamentos , Ensaio de Imunoadsorção Enzimática , Vetores Genéticos/genética , Camundongos , Camundongos Endogâmicos BALB C , Microesferas , Mimetismo Molecular/genética , Dados de Sequência Molecular , Biblioteca de Peptídeos , Peptídeos/química , Peptídeos/genética , Vacinas Pneumocócicas/genética , Vacinas Pneumocócicas/imunologia , Vacinação , Vacinas de DNA/genética
4.
Int Rev Immunol ; 20(2): 251-61, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11878768

RESUMO

Anti-idiotypic antibodies and peptides which mimic antigens may offer an alternate strategy for converting a thymus-independent (TI) antigen to a thymus dependent (TD) antigen. We have developed an anti-idiotype based peptide mimic of the capsular polysaccharide of N. meningitidis serogroup C (MCPS) which induces a T-dependent protective immune response in mice. Subsequent studies have demonstrated that immunization of severe combined immunodeficient mice reconstituted with human B cells respond to immunization with the MCPS peptide mimic with bactericidal anti-polysaccharide directed antibody response. We hypothesized that administration of a DNA vaccine resulting in endogenous expression of this carbohydrate peptide mimic would induce anti-MCPS antibodies.


Assuntos
Cápsulas Bacterianas/imunologia , Vacinas Meningocócicas/imunologia , Neisseria meningitidis/imunologia , Peptídeos/imunologia , Animais , Anticorpos Anti-Idiotípicos/imunologia , Anticorpos Antibacterianos/biossíntese , Anticorpos Monoclonais/imunologia , Humanos , Infecções Meningocócicas/imunologia , Infecções Meningocócicas/prevenção & controle , Camundongos , Mimetismo Molecular , Neisseria meningitidis/classificação , Vacinas de DNA/imunologia , Vacinas Sintéticas/imunologia
5.
Vaccine ; 19(7-8): 764-78, 2000 Nov 22.
Artigo em Inglês | MEDLINE | ID: mdl-11115698

RESUMO

A DNA vaccine against the hepatitis B virus (HBV) was evaluated for safety and induction of immune responses in 12 healthy, hepatitis-naïve human volunteers using the needle-free PowderJect system to deliver gold particles coated with DNA directly into cells of the skin. Three groups of four volunteers received three administrations of DNA encoding the surface antigen of HBV at one of the three dose levels (1, 2, or 4 microg). The vaccine was safe and well tolerated, causing only transient and mild to moderate responses at the site of administration. HBV-specific antibody and both CD4+ and CD8+ T cell responses were measured before and after each immunization. All the volunteers developed protective antibody responses of at least 10 mIU/ml. In volunteers who were positive for the HLA class I A2 allele, the vaccine also induced antigen-specific CD8+ T cells that bound HLA-A2/HBsAg(335-343) tetramers, secreted IFN-gamma, and lysed target cells presenting a hepatitis B surface antigen (HBsAg) CTL epitope. Enumeration of HBsAg-specific T cells producing cytokine indicated preferential induction of a Type 1 T helper cell response. These results provide the first demonstration of a DNA vaccine inducing protective antibody titers and both humoral and cell-mediated immune responses in humans.


Assuntos
Linfócitos T CD8-Positivos/imunologia , Anticorpos Anti-Hepatite B/biossíntese , Vacinas contra Hepatite B/administração & dosagem , Linfócitos T Auxiliares-Indutores/imunologia , Vacinas de DNA/administração & dosagem , Adulto , Biolística , Feminino , Ouro , Hepatite B/imunologia , Hepatite B/prevenção & controle , Antígenos de Superfície da Hepatite B/imunologia , Vacinas contra Hepatite B/efeitos adversos , Vírus da Hepatite B/genética , Vírus da Hepatite B/imunologia , Humanos , Masculino , Pessoa de Meia-Idade , Tamanho da Partícula , Plasmídeos/genética , Segurança , Vacinas de DNA/efeitos adversos
6.
J Immunol ; 164(9): 4635-40, 2000 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-10779767

RESUMO

DNA vaccines have been demonstrated to be potent in small animals but are less effective in primates. One limiting factor may be inefficient uptake of DNA by cells in situ. In this study, we evaluated whether cellular uptake of DNA was a significant barrier to efficient transfection in vivo and subsequent induction of immune responses. For this purpose, we used the technique of electroporation to facilitate DNA delivery in vivo. This technology was shown to substantially increase delivery of DNA to cells, resulting in increased expression and elevated immune responses. The potency of a weakly immunogenic hepatitis B surface Ag DNA vaccine was increased in mice, as seen by a more rapid onset and higher magnitude of anti-hepatitis B Abs. In addition, the immunogenicity of a potent HIV gag DNA vaccine was increased in mice, as seen by higher Ab titers, a substantial reduction in the dose of DNA required to induce an Ab response, and an increase in CD8+ T cell responses. Finally, Ab responses were enhanced by electroporation against both components of a combination HIV gag and env DNA vaccine in guinea pigs and rabbits. Therefore, cellular uptake of DNA is a significant barrier to transfection in vivo, and electroporation appears able to overcome this barrier.


Assuntos
Eletroporação , Anticorpos Anti-HIV/biossíntese , Anticorpos Anti-Hepatite B/biossíntese , Vacinas de DNA/administração & dosagem , Vacinas de DNA/imunologia , Vacinas contra a AIDS/administração & dosagem , Vacinas contra a AIDS/genética , Vacinas contra a AIDS/imunologia , Animais , Relação Dose-Resposta Imunológica , Feminino , Produtos do Gene env/genética , Produtos do Gene env/imunologia , Produtos do Gene gag/genética , Produtos do Gene gag/imunologia , Cobaias , HIV-1/genética , HIV-1/imunologia , Antígenos de Superfície da Hepatite B/genética , Antígenos de Superfície da Hepatite B/imunologia , Vacinas contra Hepatite B/administração & dosagem , Vacinas contra Hepatite B/genética , Vacinas contra Hepatite B/imunologia , Injeções Intramusculares , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Nus , Coelhos , Vacinas de DNA/genética
7.
Dev Biol (Basel) ; 104: 115-9, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11713809

RESUMO

We are developing a DNA vaccine toward hepatitis-B virus (HBV) using PowderJect's proprietary needle-free technology to deliver DNA-coated gold particles directly into cells of the skin. Preclinical studies in animals showed that (i) microgram doses of the DNA vaccine were sufficient to immunize pigs and non-human primates to antibody levels comparable to those obtained with a commercial recombinant subunit vaccine; (ii) the DNA vaccine was effective in mouse strains that respond poorly to protein subunit vaccines; (iii) the vaccine induces robust cytotoxic T-cell responses, and (iv) the vaccine is non-toxic and well tolerated. Based on these findings, this DNA vaccine was evaluated for safety, tolerability, and the induction of immune responses in phase 1 clinical studies in healthy, hepatitis-naïve human volunteers. Preliminary results indicate that the vaccine is safe and well tolerated, and elicits both humoral and cellular immune responses in man.


Assuntos
Biolística/métodos , Vacinas contra Hepatite B/administração & dosagem , Vacinas de DNA/administração & dosagem , Animais , Biolística/instrumentação , Tolerância a Medicamentos , Haplorrinos , Anticorpos Anti-Hepatite B/biossíntese , Vacinas contra Hepatite B/efeitos adversos , Vacinas contra Hepatite B/genética , Vacinas contra Hepatite B/imunologia , Humanos , Suínos , Linfócitos T Citotóxicos/imunologia , Vacinas de DNA/efeitos adversos , Vacinas de DNA/imunologia
8.
Vaccine ; 17(22): 2826-9, 1999 Jul 16.
Artigo em Inglês | MEDLINE | ID: mdl-10438052

RESUMO

This study was designed to determine the safety and immunogenicity in volunteers of a DNA vaccine consisting of a plasmid encoding hepatitis B surface antigen delivered by the PowderJect XR1 gene delivery system into human skin. Seven healthy adult volunteers received two immunizations at one of three forces of delivery on day 0 and 56. The vaccine was well tolerated. One of six seronegative volunteers developed high titers of persistent HBsAb after a single immunization. In retrospect, this volunteer may have had previous exposure to hepatitis B. Our study suggests that the hepatitis B DNA vaccine given by this gene delivery system may induce a booster response, but the vaccine at the extremely low DNA dose used (0.25 microg) did not induce primary immune responses.


Assuntos
Antígenos de Superfície da Hepatite B/genética , Antígenos de Superfície da Hepatite B/imunologia , Vacinas contra Hepatite B/uso terapêutico , Vírus da Hepatite B/genética , Vírus da Hepatite B/imunologia , Hepatite B/imunologia , Hepatite B/prevenção & controle , Vacinas de DNA/uso terapêutico , Adolescente , Adulto , Anticorpos Antivirais/sangue , DNA Viral/efeitos adversos , DNA Viral/uso terapêutico , Sistemas de Liberação de Medicamentos/efeitos adversos , Vacinas contra Hepatite B/efeitos adversos , Humanos , Imunidade nas Mucosas/imunologia , Injeções Intradérmicas/efeitos adversos , Pessoa de Meia-Idade , Vacinas de DNA/efeitos adversos
9.
Mol Med ; 5(5): 287-300, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10390545

RESUMO

BACKGROUND: In spite of the large number of studies that have evaluated DNA-based immunization, few have directly compared the immune responses generated by different routes of immunization, particularly in non-human primates. Here we examine the ability of a hepatitis B surface antigen (HBsAg)-encoding plasmid to induce immune responses in mice and non-human primates (rhesus monkeys: Macaca mulatta) after delivery by a number of routes. MATERIALS AND METHODS: Eight different injected [intraperitoneal (IP), intradermal (ID), intravenous (IV), intramuscular (IM), intraperineal (IPER), subcutaneous (SC), sublingual (SL), vaginal wall (VW)] and six noninjected [intranasal inhalation (INH), intranasal instillation (INS), intrarectal (IR), intravaginal (IVAG), ocular (Oc), oral feeding (oral)] routes and the gene gun (GG) were used to deliver HBsAg-expressing plasmid DNA to BALB/c mice. Sera were assessed for HBsAg-specific antibodies (anti-HBs, IgG, IgG1, IgG2a) and cytotoxic T lymphocyte (CTL) activity measured. Three of the most commonly used routes (IM, ID, GG) were compared in rhesus monkeys, also using HBsAg-expressing vectors. Monkeys were immunized with short (0-, 4- and 8-week) or long (0-, 12- and 24-week) intervals between boosts, and in the case of GG, also with different doses, and their sera were assessed for anti-HBs. RESULTS: In one study, anti-HBs were detected in plasma of mice treated by five of eight of the injected and none of the six noninjected routes. The highest levels of anti-HBs were induced by IM and IV injections, although significant titers were also obtained with SL and ID. Each of these routes also induced CTL, as did IPER and VW and one noninjected route (INH) that failed to induce antibodies. In a second study, GG (1.6 microg) was compared to ID and IM (100 microg) delivery. Significant titers were obtained by all routes after only one boost, with the highest levels detected by IM. Delivery to the skin by GG induced exclusively IgG1 antibodies (Th2-like) at 4 weeks and only very low IgG2a levels at later times; ID-immunized mice had predominantly IgG1 at 4 weeks and this changed to mixed IgG1/IgG2a over time. Responses with IM injection (in the leg or tongue) were predominantly IgG2a (Th1-like) at all times. IV injection gave mixed IgG1/IgG2a responses. In monkeys, in the first experiment, 1 mg DNA IM or ID at 0, 4, and 8 weeks gave equivalent anti-HB titers and 0.4 microg at the same times by GG induced lower titers. In the second experiment, 1 mg DNA IM or ID, or 3.2 microg by GG, at 0, 12, and 24 weeks, gave anti-HB values in the hierarchy of GG > IM > ID. Furthermore, high titers were retained after a single immunization in mice but fell off over time in the monkeys, even after boost. CONCLUSIONS: Route of administration of plasmid DNA vaccines influences the strength and nature of immune responses in mice and non-human primates. However, the results in mice were not always predictive of those in monkeys and this is likely true for humans as well. Optimal dose and immunization schedule will most likely vary between species. It is not clear whether results in non-human primates will be predictive of results in humans, thus additional studies are required. http://link.springer-ny.com/link/service/journals/00020/bibs /5n5p287. html


Assuntos
Vacinas contra Hepatite B/administração & dosagem , Vacinas contra Hepatite B/imunologia , Vacinas de DNA/administração & dosagem , Administração Cutânea , Administração Intranasal , Administração Oral , Animais , Formação de Anticorpos , Feminino , Antígenos de Superfície da Hepatite B/genética , Antígenos de Superfície da Hepatite B/imunologia , Imunidade Celular , Injeções Intramusculares , Injeções Intravenosas , Macaca mulatta , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Valor Preditivo dos Testes , Linfócitos T Citotóxicos/imunologia , Fatores de Tempo
10.
J Virol ; 72(6): 5174-81, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9573289

RESUMO

Our previous studies have shown that isolated cytotoxic T lymphocyte (CTL), B-cell, and T-helper epitopes, for which we coined the term minigenes, can be effective vaccines; when expressed from recombinant vaccinia viruses, these short immunogenic sequences confer protection against a variety of viruses and bacteria. In addition, we have previously demonstrated the utility of DNA immunization using plasmids encoding full-length viral proteins. Here we combine the two approaches and evaluate the effectiveness of minigenes in DNA immunization. We find that DNA immunization with isolated minigenes primes virus-specific memory CTL responses which, 4 days following virus challenge, appear similar in magnitude to those induced by vaccines known to be protective. Surprisingly, this vigorous CTL response fails to confer protection against a normally lethal virus challenge, although the CTL appear fully functional because, along with their high lytic activity, they are similar in affinity and cytokine secretion to CTL induced by virus infection. However this DNA immunization with isolated minigenes results in a low CTL precursor frequency; only 1 in approximately 40,000 T cells is epitope specific. In contrast, a plasmid encoding the same minigene sequences covalently attached to the cellular protein ubiquitin induces protective immunity and a sixfold-higher frequency of CTL precursors. Thus, we show that the most commonly employed criterion to evaluate CTL responses-the presence of lytic activity following secondary stimulation-does not invariably correlate with protection; instead, the better correlate of protection is the CTL precursor frequency. Recent observations indicate that certain effector functions are active in memory CTL and do not require prolonged stimulation. We suggest that these early effector functions of CTL, immediately following infection, are critical in controlling virus dissemination and in determining the outcome of the infection. Finally, we show that improved performance of the ubiquitinated minigenes most probably requires polyubiquitination of the fusion protein, suggesting that the enhancement results from more effective delivery of the minigene to the proteasome.


Assuntos
Citotoxicidade Imunológica , DNA Viral/imunologia , Memória Imunológica , Linfócitos T Citotóxicos/imunologia , Vacinas Virais/imunologia , Animais , DNA Viral/administração & dosagem , Genes Virais , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Dados de Sequência Molecular , Plasmídeos
11.
Behring Inst Mitt ; (98): 73-8, 1997 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9382772

RESUMO

Polynucleotide vaccines are a new approach to immunization that promises qualitative advances in vaccine technology. These vaccines mimic infection in that they result in expression of pathogen gene products in situ, which can elicit both cell-mediated immune responses and humoral responses. This approach has been applied primarily to vaccines against viral diseases, but may be significant for vaccines directed toward bacterial pathogens. Auragen has developed a generally applicable gene transfer technology and, for vaccine applications, has focused on particle-mediated gene transfer to epidermis. Results demonstrate that Accell polynucleotide vaccines induce immune responses toward human immunodefficiency virus (HIV) antigens, influenza A virus antigens, and hepatitis B virus (HBV) antigens in rodent,s swine and primates. Cellular immune responses toward these antigens have been demonstrated in rodents. In a swine influenza a challenge model Accell vaccination provides protection equivalent to that of a commercial killed-whole-virus vaccine. Vaccination of mice by this method toward a Chlamydia pneumoniae major outer-membrane protein elicits a species-specific antibody response.


Assuntos
Vacinas Bacterianas , Técnicas de Transferência de Genes , Vacinas de DNA , Vacinas Virais , Vacinas contra a AIDS , Animais , Formação de Anticorpos , Infecções por Chlamydia/imunologia , Infecções por Chlamydia/prevenção & controle , Vacinas contra Hepatite B , Humanos , Imunidade nas Mucosas , Vacinas contra Influenza , Camundongos , Primatas , Pele/imunologia , Suínos
12.
J Biotechnol ; 44(1-3): 37-42, 1996 Jan 26.
Artigo em Inglês | MEDLINE | ID: mdl-8717384

RESUMO

Nucleic acid immunization involves the direct in vivo administration of antigen-encoding plasmid DNA molecules that results in the de novo production of correctly folded microbial antigens at the site of DNA delivery. While this process can lead to the development of neutralizing antibody responses recognizing authentic protein conformations, in vivo antigen production also results in epitope presentation via the MHC class I antigen processing pathway, leading to the elicitation of cytotoxic cellular immune responses. Recent efforts in the authors' laboratories have focused on use of the Accell gene delivery system (gene gun) to achieve the direct, intracellular delivery of small quantities of DNA into cells of the epidermis. The gene gun approach to nucleic acid vaccination capitalizes on the synergistic combination of an effective DNA delivery system and a target tissue that serves as a major immunological inductive site. Experimental gene gun-based nucleic acid vaccines can achieve potent humoral and cytotoxic cellular immune responses in rodent models following immunization with as little as 16 ng of DNA. Equally strong responses have also been elicited in larger animals, such as pigs and monkeys, following epidermal immunization with as little as 2 to 4 micrograms of DNA.


Assuntos
Antígenos/biossíntese , Antígenos/imunologia , DNA/administração & dosagem , Terapia Genética , Imunização , Plasmídeos/administração & dosagem , Animais , Formação de Anticorpos , DNA/metabolismo , Epitopos/imunologia , Haplorrinos , Humanos , Imunização/instrumentação , Imunização/métodos , Injeções Intradérmicas , Roedores , Suínos
13.
Gene Ther ; 3(1): 67-74, 1996 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8929913

RESUMO

We sought to amplify the immune response to polynucleotide immunization through co-delivery of complementary DNA (cDNA) encoding a cytokine or co-stimulatory molecule to enhance antigen presentation. In the context of intramuscular immunization, we examined co-delivery of cDNAs for B7-1 and human carcinoembryonic antigen (CEA) within separate plasmids or a dual plasmid with two independent expression cassettes. Intramuscular delivery of the dual expression plasmid produced anti-CEA antibody responses and antitumor effects superior to those generated by plasmid DNA encoding CEA alone. However, co-delivery of cDNAs encoding B7-1 and CEA in the form of two separate plasmids produced no augmentation. The importance of single plasmid delivery suggests the effectiveness of this strategy is contingent upon co-expression of B7-1 and CEA within the same cell. The success of cutaneous polynucleotide immunization by particle bombardment is thought to derive largely from the presence of Langerhans cells within the skin. We hypothesized that co-delivery of plasmid DNA encoding granulocyte-macrophage colony stimulating factor (GM-CSF) by particle bombardment would enhance the antigen presenting capacity of Langerhans cells at the inoculation site similar to its effects in vitro. Augmentation of CEA-specific lymphoblastic transformation and antibody response was observed when plasmid GM-CSF (pGM-CSF) was administered 3 days prior to each dose of plasmid DNA encoding CEA. These strategies for augmentation of immune response to polynucleotide immunization should be applicable to a wide variety of antigenic targets including infectious agents and other tumor-associated antigens.


Assuntos
Antígeno B7-1/genética , Antígeno Carcinoembrionário/genética , Expressão Gênica , Fator Estimulador de Colônias de Granulócitos e Macrófagos/genética , Animais , Antígeno B7-1/imunologia , Antígeno Carcinoembrionário/imunologia , Feminino , Fator Estimulador de Colônias de Granulócitos e Macrófagos/imunologia , Células HeLa , Humanos , Imunização , Camundongos , Camundongos Endogâmicos C57BL , Polinucleotídeos/imunologia , Células Tumorais Cultivadas
15.
Ann Surg ; 222(3): 229-39; discussion 239-42, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7677454

RESUMO

OBJECTIVE: The authors investigated whether adenoviral gene transfer to the thymus could be accomplished in vivo and whether immunologic unresponsiveness to recombinant adenovirus could be induced by intrathymic inoculation. SUMMARY BACKGROUND DATA: A major barrier to the clinical application of adenovirus-mediated gene therapy for diseases requiring long-lasting gene expression is the immunogenicity of adenoviral vectors, which limits the duration of its effects. In other experimental models, intrathymic inoculation of foreign proteins or cells has proven to be an effective means to induce immunologic tolerance. METHODS: The efficiency of gene transfer to the mouse thymus after direct inoculation of recombinant adenovirus was compared with that of several other vectors. Animals inoculated with adenovirus-infected pancreatic islets into the thymus were tested for unresponsiveness to the virus with a subsequent challenge of adenovirus administered into the liver by intravenous injection. RESULTS: Adenovirus accomplished highly efficient gene transfer to the thymus, unlike plasmid DNA, DNA-liposome complexes, retrovirus, and adeno-associated virus. Adenoviral transgene expression was transient in the thymus of immunocompetent mice but persistent in CD8+ T-cell-deficient and severe combined immunodeficiency (SCID) mice, implicating the role of cytotoxic T lymphocytes in viral clearance. Intrathymic transplantation of syngeneic pancreatic islet cells infected with adenovirus impaired the normal antiviral cytotoxic T-lymphocyte response and prolonged hepatic transgene expression after an intravenous challenge with adenovirus. CONCLUSIONS: Recombinant adenovirus accomplishes highly efficient gene transfer to the thymus in vivo. Intrathymic inoculation of adenovirus-infected islets can be used to induce immunologic unresponsiveness to the adenoviral vector and, potentially, to other proteins that it might be engineered to encode.


Assuntos
Adenoviridae/genética , Técnicas de Transferência de Genes , Timo/imunologia , Animais , Formação de Anticorpos , Feminino , Tolerância Imunológica , Ilhotas Pancreáticas/virologia , Óperon Lac/genética , Camundongos , Camundongos Endogâmicos C57BL , Plasmídeos , Linfócitos T Citotóxicos/imunologia , Timo/virologia
16.
J Immunol ; 148(1): 272-6, 1992 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-1727871

RESUMO

We have generated a chimeric protein molecule composed of the alpha- and beta-chains of the MHC class II I-E molecule fused to antibody V regions derived from anti-human CD4 mAb MT310. Expression vectors were constructed containing the functional, rearranged gene segments coding for the V region domains of the antibody H and L chains in place of the first domains of the complete structural genes of the I-E alpha- and beta-chains, respectively. Cells transfected with both hybrid genes expressed a stable protein product on the cell surface. The chimeric molecule exhibited the idiotype of the antibody MT310 as shown by binding to the anti-idiotypic mAb 20-46. A protein of the anticipated molecular mass was immunoprecipitated with anti-mouse IgG antiserum. Furthermore, human soluble CD4 did bind to the transfected cell line, demonstrating that the chimeric protein possessed the binding capacity of the original mAb. Thus, the hybrid molecule retained: 1) the properties of a MHC class II protein with regard to correct chain assembly and transport to the cell surface; as well as 2) the Ag binding capacity of the antibody genes used. The generation of hybrid MHC class II molecules with highly specific, non-MHC-restricted binding capacities will be useful for studying MHC class II-mediated effector functions such as selection of the T cell repertoire in thymus of transgenic mice.


Assuntos
Genes de Imunoglobulinas , Genes MHC da Classe II , Antígenos de Histocompatibilidade Classe II/genética , Região Variável de Imunoglobulina/genética , Proteínas Recombinantes de Fusão/genética , Animais , Sítios de Ligação de Anticorpos , Antígenos CD4/imunologia , Membrana Celular/metabolismo , Eletroforese em Gel Bidimensional , Citometria de Fluxo , Região Variável de Imunoglobulina/metabolismo , Técnicas In Vitro , Camundongos , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/metabolismo
17.
Biol Reprod ; 43(4): 684-93, 1990 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1963095

RESUMO

Previous experiments revealed that male transgenic mice bearing a cosmid that included the Class II E alpha gene, about 35 kb of 5' flanking DNA, and the cosmid vector sequences were sterile. To ascertain the cause of the sterility, various subfragments of the cosmid were tested in transgenic mice. Only those pieces of DNA that included some of the E alpha flanking chromosomal DNA and the herpes simplex virus (HSV)-thymidine kinase (tk) gene that was in the vector resulted in male sterility. Histological analysis revealed abnormalities in nuclear morphology of elongating spermatids and retention of mature spermatids within the seminiferous epithelium. Immunocytochemical studies showed that the HSV-tk gene was expressed at low levels in postmeiotic round spermatids and at higher levels in more mature elongating spermatids. To determine whether expression of HSV-tk in spermatids might be responsible for the sterility, the protamine gene promoter was used to direct the expression of HSV-tk to postmeiotic germ cells. Since the mice so treated were also sterile, the data suggest that expression of this enzyme in spermatids is responsible for the sterility phenotype.


Assuntos
Infertilidade Masculina/genética , Camundongos Transgênicos/fisiologia , Animais , Mapeamento Cromossômico , Clonagem Molecular , Cosmídeos/genética , Feminino , Expressão Gênica , Vetores Genéticos/genética , Infertilidade Masculina/patologia , Infertilidade Masculina/fisiopatologia , Masculino , Meiose/fisiologia , Camundongos , Fenótipo , Protaminas/genética , Protaminas/metabolismo , Simplexvirus/enzimologia , Simplexvirus/genética , Espermatogênese/fisiologia , Espermatozoides/metabolismo , Espermatozoides/patologia , Espermatozoides/fisiologia , Testículo/metabolismo , Testículo/patologia , Testículo/fisiopatologia , Timidina Quinase/genética
18.
Biotechniques ; 8(4): 370-1, 1990 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-1692715

RESUMO

We describe a simplified Northern blot hybridization procedure. This procedure eliminates the need for many reagents commonly used in RNA hybridization and replaces them with two buffers containing 5% sodium dodecyl sulfate for pre-hybridization, hybridization and all post-hybridization washes.


Assuntos
Dodecilsulfato de Sódio , Animais , Northern Blotting/métodos , Sondas de DNA , Camundongos , Hibridização de Ácido Nucleico , RNA/análise
19.
Cell ; 53(1): 159-68, 1988 Apr 08.
Artigo em Inglês | MEDLINE | ID: mdl-2964908

RESUMO

Insulin-dependent diabetes is caused by the loss of insulin-producing beta cells in pancreatic islets. It has been proposed that aberrant expression of Class II Major Histocompatibility Complex (MHC) molecules on beta cells stimulates an autoimmune attack against beta cell antigens. To test this hypothesis, we generated transgenic mice that express Class II MHC molecules (E alpha d/E beta b, or I-Eb) on beta cells. Diabetes was found in 100% of transgenic progeny from three expressing transgenic mouse lines, but without evidence for lymphocytic infiltrates. Furthermore, T lymphocytes appeared to be tolerant to the transgene I-Eb molecule, despite the absence of expression of I-Eb in the thymus or any other lymphoid tissue. The results suggest that novel expression of Class II MHC molecules on nonlymphoid cells is by itself insufficient to initiate autoimmune responses against tissue-specific antigens.


Assuntos
Diabetes Mellitus Experimental/imunologia , Antígenos HLA-D/genética , Ilhotas Pancreáticas/imunologia , Complexo Principal de Histocompatibilidade , Animais , Teste de Cultura Mista de Linfócitos , Camundongos , Camundongos Endogâmicos , Camundongos Transgênicos , RNA Mensageiro/genética , Linfócitos T/imunologia , Transcrição Gênica
20.
Cell ; 51(2): 175-87, 1987 Oct 23.
Artigo em Inglês | MEDLINE | ID: mdl-3499228

RESUMO

The E alpha MHC class II gene with 1.4 kb of 5'-flanking and 0.5 kb of 3'-flanking sequences was introduced into (H-2b X s)F2 mice, which do not express their endogenous E alpha gene. The transgene was expressed in thymic tissue and in adherent spleen cells and was induced in peritoneal exudate cells by gamma-interferon. In contrast to the normal E alpha gene, there was no expression in B lymphocytes. Since transgenic animals made with constructs containing 3.2 kb and 2 kb of 5'-flanking sequences show normal expression pattern of the E alpha gene, it appears that deletion of 5'-flanking sequences between -1.4 kb and -2 kb inactivated or eliminated regulatory sequences required for expression of E alpha specifically in B cells. The presence of pBR327 DNA linked to the -1.4 kb E alpha transgene suppresses expression in peripheral adherent cells, yielding mice expressing E alpha only in the thymus. These mice appear to be tolerant to I-E, as measured in mixed leukocyte response experiments.


Assuntos
Linfócitos B/imunologia , Antígenos de Histocompatibilidade Classe II/genética , Antígenos de Histocompatibilidade Classe II/imunologia , Complexo Principal de Histocompatibilidade , Camundongos Transgênicos/imunologia , Animais , Sequência de Bases , Deleção Cromossômica , Elementos Facilitadores Genéticos , Genes , Vetores Genéticos , Camundongos , Camundongos Transgênicos/genética , Dados de Sequência Molecular , Plasmídeos , Biossíntese de Proteínas , Timo/citologia , Timo/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA